Altered peripheral immune profiles in treatment-resistant depression: response to ketamine and prediction of treatment outcome
Drew D. Kiraly(Allen Institute for Brain Science), James W. Murrough(Allen Institute for Brain Science), Nicholas T. Van Dam(The University of Melbourne), Scott J. Russo(Allen Institute for Brain Science), Manishkumar Patel(Icahn School of Medicine at Mount Sinai), Dan V. Iosifescu(Nathan Kline Institute for Psychiatric Research), Sara Costi(Oxford Health NHS Foundation Trust), Seunghee Kim‐Schulze(Icahn School of Medicine at Mount Sinai), Miriam Mérad(Icahn School of Medicine at Mount Sinai), Sarah R. Horn(Boston University), Dennis S. Charney(National Institute of Mental Health), Jaclyn Schwartz(Icahn School of Medicine at Mount Sinai), Georgia E. Hodes(Virginia Tech)
Cited by 181
Related Papers
An inflammatory cytokine signature predicts COVID-19 severity and survival
|Nature Medicine|2020|2.7k
Molecular Adaptations Underlying Susceptibility and Resistance to Social Defeat in Brain Reward Regions
|Cell|2007|2.3k
Immunology of COVID-19: Current State of the Science
|Immunity|2020|1.8k